ZIMMER BIOMET HOLDINGS INC shares fell 7% Tuesday after the medical device maker maintained its 1% to 3% revenue growth forecast for 2026. The cautious outlook follows a United States sales force overhaul that caused the loss of two large customer accounts this quarter. Investors are weighing a $0.10 raise in profit guidance against execution risks as the company restructures its commercial model.
Zimmer Biomet Shares Drop Despite Profit Forecast Raise
The medical device maker maintained its annual revenue outlook amid a U.S. sales force transition. Shares fell 7% today despite a raised full-year profit forecast.
Xurve View
洞察:
Xurve View











